More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Roche v. Aetna, Inc.
Healthcare, Notable
Lowey Dannenberg is defending Aetna in a class action related to state anti-subrogation laws. Minerley v. Aetna Inc., et al., 13-cv-1337 (D.N.J.). Lowey Dannenberg has defended and won dismissal of […]
Federated Investment Management Company, et al., v. Republic of Argentina
Antitrust
Lowey obtained emergency injunctive relief on behalf of Federated Investors, one of the largest investment firms in the country with over $363 billion in assets under management, preventing the Government […]
Juniper Networks
Notable
Lowey Dannenberg served as lead counsel, representing the New York City Pension Funds and related class members, alleging that Juniper Networks, Inc. fraudulently concealed the backdating of millions of stock […]
News
Lowey’s Noelle Feigenbaum Receives 2021 AAI Award for Outstanding Antitrust Litigation Achievement by a Young Lawyer
On November 11, 2021, Noelle Feigenbaum was honored by the American Antitrust Institute ("AAI") with the Outstanding Antitrust Litigation Achievement by a Young Lawyer award, one of two attorneys to receive the award. She was joined at AAI’s 15th annual Private...
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had...